wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36223538-1D4A0222-3A01-443A-B7BB-2AD37D6D302B
Q36223538-1D4A0222-3A01-443A-B7BB-2AD37D6D302B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36223538-1D4A0222-3A01-443A-B7BB-2AD37D6D302B
A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib
P2860
Q36223538-1D4A0222-3A01-443A-B7BB-2AD37D6D302B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36223538-1D4A0222-3A01-443A-B7BB-2AD37D6D302B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
94d36810d07b3184135d2fb01b1979d1d5978281
P2860
A phase I/II trial of the oral antiangiogenic agent TSU-68 in patients with advanced hepatocellular carcinoma.